BIO-Key International Inc reports results for the quarter ended June 30 - Earnings Summary

• BIO-Key International Inc BKYI.OQ reported a quarterly adjusted loss of 20 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.00. The lone analyst forecast for the quarter was for a loss of 15 cents per share.

• Revenue rose 48.7% to $1.70 million from a year ago; analysts expected $1.70 million.

• The company reported a quarterly loss of $1.17 million.

• BIO-Key International Inc shares had fallen by 1.1% this quarter and lost 52.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 7.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the electronic equipment & parts peer group is also "buy"

• Wall Street's median 12-month price target for BIO-Key International Inc is $2.00, about 59.6% above its last closing price of $0.81

This summary was machine generated from LSEG data August 13 at 12:47 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)